EP3023095

Samsetning fyrir beinan töfluslátt og aðferð

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    17.1.2005
  • EP published:
    16.5.2018
  • EP application number:
    15199440.7
  • Max expiry date:
    16.1.2025
  • Expiry date:
    16.1.2024
  • Title:
    DIRECT COMPRESSION FORMULATION AND PROCESS

Timeline

Today
17.1.2005EP application
16.5.2018EP Publication
2.8.2018Translation submitted
15.8.2018Registration published
16.1.2024Expires

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056, Basel, CH

Inventor

  • Name:
    Kowalski, James
  • Address:
    Belle Mead, NJ, US
  • Name:
    Lakshman, Jay Parthiban
  • Address:
    Bridgewater, NJ, US
  • Name:
    Patel, Arun P.
  • Address:
    Succasunna, NJ, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    537706 P
  • Date:
    20.1.2004
  • Country:
    US
  • Number:
    604274 P
  • Date:
    25.8.2004
  • Country:
    US

Classification

  • Categories:
    A61K 9/20

Annual fees

Number

Paid

Expires

Payer

Number: 15

Paid: 2.1.2019

Expires: 16.1.2020

Payer: Árnason Faktor

Number: 16

Paid: 31.12.2019

Expires: 16.1.2021

Payer: Árnason Faktor ehf.

Number: 17

Paid: 29.12.2020

Expires: 16.1.2022

Payer: Árnason Faktor ehf.

Number: 18

Paid: 28.12.2021

Expires: 16.1.2023

Payer: Árnason Faktor ehf.

Number: 19

Paid: 22.12.2022

Expires: 16.1.2024

Payer: Árnason Faktor ehf.

Upload documents